|
|
|
Insider
Information: |
Marlett Christopher A |
Relationship: |
Director |
City: |
Santa Monica |
State: |
CA |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
4 |
|
Direct
Shares |
3,125,516 |
|
Indirect Shares
|
1,723,699 |
|
|
Direct
Value |
$2,666,699 |
|
|
Indirect Value
|
$1,524,043 |
|
|
Total
Shares |
4,849,215 |
|
|
Total
Value |
$4,190,742 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
2
|
Stock
price went up :
|
0
|
2
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
2.0
|
Percentage
Gain/Loss : |
0.0%
|
3.3%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Medivation Inc |
MDVN |
Director, 10% Owner |
2004-12-17 |
0 |
2004-12-17 |
574,736 |
Premium* |
|
Arena Group Hldgs Ord Shs |
AREN |
Director, 10% Owner |
2017-12-05 |
3,033,279 |
|
0 |
Premium* |
|
Clearsign Combustion Corp |
CLIR |
Former 10% Owner |
2012-05-09 |
92,237 |
2012-05-09 |
380,460 |
Premium* |
|
Cue Biopharma, Inc. |
CUE |
Director |
2019-12-31 |
0 |
2019-12-31 |
768,503 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
62 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 3
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
AREN |
Arena Group Hldgs Ord Shs |
CEO |
|
2014-07-14 |
4 |
A |
$0.16 |
$5,770 |
D/D |
36,063 |
2,499,506 |
0 |
- |
|
AREN |
Arena Group Hldgs Ord Shs |
CEO |
|
2014-10-21 |
4 |
A |
$0.18 |
$6,250 |
D/D |
34,723 |
2,534,229 |
0 |
- |
|
AREN |
Arena Group Hldgs Ord Shs |
CEO |
|
2015-01-08 |
5 |
A |
$0.15 |
$6,250 |
D/D |
41,667 |
2,575,896 |
0 |
- |
|
AREN |
Arena Group Hldgs Ord Shs |
CEO |
|
2015-04-13 |
5 |
A |
$0.15 |
$6,250 |
D/D |
41,667 |
2,617,563 |
0 |
- |
|
AREN |
Arena Group Hldgs Ord Shs |
CEO |
|
2015-07-10 |
5 |
A |
$0.15 |
$6,250 |
D/D |
41,667 |
2,659,230 |
0 |
- |
|
AREN |
Arena Group Hldgs Ord Shs |
CEO |
|
2015-10-12 |
5 |
A |
$0.15 |
$6,250 |
D/D |
41,667 |
2,703,897 |
0 |
- |
|
AREN |
Arena Group Hldgs Ord Shs |
Director |
|
2016-01-11 |
4 |
A |
$0.15 |
$6,250 |
D/D |
41,667 |
2,745,564 |
0 |
- |
|
AREN |
Arena Group Hldgs Ord Shs |
Director |
|
2016-04-12 |
4 |
A |
$0.16 |
$6,250 |
D/D |
39,063 |
2,784,627 |
0 |
- |
|
AREN |
Arena Group Hldgs Ord Shs |
Director |
|
2016-07-11 |
4 |
A |
$0.16 |
$6,250 |
D/D |
39,063 |
2,823,690 |
0 |
- |
|
AREN |
Arena Group Hldgs Ord Shs |
Director |
|
2016-10-04 |
4 |
A |
$0.20 |
$6,250 |
D/D |
31,251 |
2,854,941 |
0 |
- |
|
AREN |
Arena Group Hldgs Ord Shs |
Director |
|
2017-01-18 |
4 |
A |
$1.11 |
$6,608 |
D/D |
5,953 |
2,860,894 |
0 |
- |
|
AREN |
Arena Group Hldgs Ord Shs |
Director |
|
2017-04-04 |
4 |
B |
$1.24 |
$133,585 |
D/D |
107,730 |
2,968,624 |
3.92 |
- |
|
AREN |
Arena Group Hldgs Ord Shs |
Director |
|
2017-12-01 |
4 |
B |
$1.50 |
$22,830 |
D/D |
14,800 |
2,983,424 |
3.92 |
- |
|
AREN |
Arena Group Hldgs Ord Shs |
Director |
|
2017-12-04 |
4 |
B |
$1.44 |
$28,526 |
D/D |
19,025 |
3,002,449 |
3.92 |
- |
|
AREN |
Arena Group Hldgs Ord Shs |
Director |
|
2017-12-05 |
4 |
B |
$1.35 |
$43,851 |
D/D |
30,830 |
3,033,279 |
3.92 |
- |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2018-12-11 |
4 |
B |
$4.86 |
$36,659 |
I/I |
7,543 |
7,543 |
2.1 |
- |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2018-12-12 |
4 |
B |
$5.09 |
$45,810 |
D/D |
9,000 |
9,000 |
2.39 |
- |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2018-12-12 |
4 |
B |
$5.07 |
$16,168 |
I/I |
3,189 |
10,732 |
2.1 |
- |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2018-12-13 |
4 |
B |
$5.06 |
$50,600 |
I/I |
10,000 |
20,732 |
2.1 |
- |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2018-12-18 |
4 |
B |
$5.20 |
$19,053 |
I/I |
3,664 |
24,396 |
2.1 |
- |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2018-12-19 |
4 |
B |
$5.00 |
$2,000 |
I/I |
400 |
24,796 |
2.02 |
- |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2018-12-20 |
4 |
B |
$4.74 |
$44,736 |
I/I |
9,438 |
34,234 |
2.1 |
- |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2018-12-21 |
4 |
B |
$4.53 |
$77,916 |
I/I |
17,200 |
51,434 |
2.1 |
- |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2018-12-26 |
4 |
B |
$4.29 |
$84,286 |
I/I |
19,647 |
71,081 |
2.1 |
- |
|
CUE |
Cue Biopharma, Inc. |
Director |
|
2018-12-31 |
4 |
B |
$4.64 |
$85,937 |
I/I |
18,521 |
89,602 |
2.1 |
- |
|
62 Records found
|
|
Page 2 of 3 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|